These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 27779646

  • 1. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.
    Sakamoto K, Khai NC, Wang Y, Irie R, Takamatsu H, Matsufuji H, Kosai KI.
    Int J Mol Med; 2016 Dec; 38(6):1673-1682. PubMed ID: 27779646
    [Abstract] [Full Text] [Related]

  • 2. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.
    Khai NC, Takahashi T, Ushikoshi H, Nagano S, Yuge K, Esaki M, Kawai T, Goto K, Murofushi Y, Fujiwara T, Fujiwara H, Kosai K.
    J Hepatol; 2006 Jun; 44(6):1046-54. PubMed ID: 16466829
    [Abstract] [Full Text] [Related]

  • 3. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z, Mizuno S, Nakamura T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [Abstract] [Full Text] [Related]

  • 4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice.
    Guo Y, Ding Q, Chen L, Ji C, Hao H, Wang J, Qi W, Xie X, Ma J, Li A, Jiang X, Li X, Jiang H.
    Am J Med Sci; 2017 Aug; 354(2):199-210. PubMed ID: 28864379
    [Abstract] [Full Text] [Related]

  • 6. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T, Yoshida Y, Kiso S, Kizu T, Furuta K, Ezaki H, Hamano M, Egawa M, Chatani N, Kamada Y, Imai Y, Higashiyama S, Iwamoto R, Mekada E, Takehara T.
    Biochem Biophys Res Commun; 2013 Jul 26; 437(2):185-91. PubMed ID: 23743191
    [Abstract] [Full Text] [Related]

  • 7. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N, Nagel M, Straub BK, Wörns MA, Schuchmann M, Galle PR, Schattenberg JM.
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar 01; 314(3):G319-G333. PubMed ID: 29191940
    [Abstract] [Full Text] [Related]

  • 8. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Osawa Y, Seki E, Adachi M, Suetsugu A, Ito H, Moriwaki H, Seishima M, Nagaki M.
    Hepatology; 2010 Jan 01; 51(1):237-45. PubMed ID: 19821528
    [Abstract] [Full Text] [Related]

  • 9. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis.
    Phaneuf D, Chen SJ, Wilson JM.
    Mol Med; 2000 Feb 01; 6(2):96-103. PubMed ID: 10859026
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA, Schwartz MZ, Yoo EY, Mendelson KG, Duke DS.
    J Pediatr Surg; 2008 Dec 01; 43(12):2169-73. PubMed ID: 19040928
    [Abstract] [Full Text] [Related]

  • 11. Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver.
    Ross J, Gherardi E, Mallorqui-Fernandez N, Bocci M, Sobkowicz A, Rees M, Rowe A, Ellmerich S, Massie I, Soeda J, Selden C, Hodgson H.
    Gastroenterology; 2012 Apr 01; 142(4):897-906. PubMed ID: 22178588
    [Abstract] [Full Text] [Related]

  • 12. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy.
    Kiso S, Kawata S, Tamura S, Higashiyama S, Ito N, Tsushima H, Taniguchi N, Matsuzawa Y.
    Hepatology; 1995 Nov 01; 22(5):1584-90. PubMed ID: 7590679
    [Abstract] [Full Text] [Related]

  • 13. Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats.
    Yu Y, Lu L, Qian X, Chen N, Yao A, Pu L, Zhang F, Li X, Kong L, Sun B, Wang X.
    Stem Cells Dev; 2010 Jun 01; 19(6):903-14. PubMed ID: 20025519
    [Abstract] [Full Text] [Related]

  • 14. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H, Zhang Y, Heuckeroth RO.
    Hepatology; 2007 Jun 01; 45(6):1527-37. PubMed ID: 17538930
    [Abstract] [Full Text] [Related]

  • 15. Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice.
    Gao C, Jokerst R, Gondipalli P, Cai SR, Kennedy S, Ponder KP.
    Hum Gene Ther; 1999 Apr 10; 10(6):911-22. PubMed ID: 10223725
    [Abstract] [Full Text] [Related]

  • 16. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation.
    Atta HM, Al-Hendy A, Salama SA, Shaker OG, Hammam OA.
    Liver Int; 2009 Aug 10; 29(7):1022-30. PubMed ID: 19515220
    [Abstract] [Full Text] [Related]

  • 17. The effect of hepatocyte growth factor on the initiation phase of liver regeneration after cold ischemia in a rat model of small-for-size liver transplantation.
    Hua ZY, Song J, Cheng F, Yu Y, Gao Y, Yao A, Wang X.
    Hepatogastroenterology; 2012 Aug 10; 59(117):1548-52. PubMed ID: 22683971
    [Abstract] [Full Text] [Related]

  • 18. Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors.
    Zhang D, Zhang J, Jiang X, Li X, Wang Y, Ma J, Jiang H.
    J Gastroenterol Hepatol; 2014 Mar 10; 29(3):623-32. PubMed ID: 24303948
    [Abstract] [Full Text] [Related]

  • 19. EGF and HGF levels are increased during active HBV infection and enhance survival signaling through extracellular matrix interactions in primary human hepatocytes.
    Barreiros AP, Sprinzl M, Rosset S, Höhler T, Otto G, Theobald M, Galle PR, Strand D, Strand S.
    Int J Cancer; 2009 Jan 01; 124(1):120-9. PubMed ID: 18844210
    [Abstract] [Full Text] [Related]

  • 20. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes.
    Moriuchi A, Hirono S, Ido A, Ochiai T, Nakama T, Uto H, Hori T, Hayashi K, Tsubouchi H.
    Biochem Biophys Res Commun; 2001 Jan 12; 280(1):368-73. PubMed ID: 11162525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.